Alumis, Inc. (ALMS)
23.86
+0.83
(+3.60%)
USD |
NASDAQ |
Aug 25, 14:32
Alumis Total Assets (Quarterly) : 560.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 560.62M |
| March 31, 2026 | 671.59M |
| December 31, 2025 | 416.14M |
| September 30, 2025 | 488.01M |
| June 30, 2025 | 610.92M |
| March 31, 2025 | 261.30M |
| Date | Value |
|---|---|
| December 31, 2024 | 340.99M |
| September 30, 2024 | 412.56M |
| June 30, 2024 | 265.18M |
| March 31, 2024 | 177.38M |
| December 31, 2023 | 89.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 888.70M |
| Aclaris Therapeutics, Inc. | 179.69M |
| Crinetics Pharmaceuticals, Inc. | 1.322B |
| Tarsus Pharmaceuticals, Inc. | 611.14M |
| Structure Therapeutics, Inc. | 1.425B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 108.46M |
| Shareholders Equity (Quarterly) | 452.16M |
| Debt to Equity Ratio | 0.0806 |
| Current Ratio | 6.744 |
| Net Debt Paydown Yield | -0.03% |